These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 176392)
1. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells. Aurelian L; Smith MF; Cornish DJ J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392 [TBL] [Abstract][Full Text] [Related]
2. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2. Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764 [TBL] [Abstract][Full Text] [Related]
3. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand. Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050 [No Abstract] [Full Text] [Related]
4. Sero-immunological investigations in patients with cervical cancer: higher rate of HSV-2 antibodies than in syphilis patients and evidence of IgM antibodies to an early HSV-1 antigen. Schneweis KE; Haag A; Lehmköster A; Koenig U IARC Sci Publ (1971); 1975; (11 Pt 2):53-7. PubMed ID: 191383 [No Abstract] [Full Text] [Related]
5. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity. Aurelian L; Kessler II; Rosenshein NB; Barbour G Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662 [TBL] [Abstract][Full Text] [Related]
6. Herpes virus-related antigens in herpes simplex virus type 2-transformed cells in the course of cervical carcinoma. Christenson B Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1345-52. PubMed ID: 6299751 [TBL] [Abstract][Full Text] [Related]
8. Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients. Arsenakis M; May JT Infect Immun; 1981 Jul; 33(1):22-8. PubMed ID: 6266964 [TBL] [Abstract][Full Text] [Related]
9. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls. Aurelian L; Cornish JD; Smith MF IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387 [No Abstract] [Full Text] [Related]
10. Immunodiagnostic potential of a virus-coded, tumor-associated antigen (AG-4) in cervical cancer. Aurelian L; Strnad BC; Smith MF Cancer; 1977 Apr; 39(4 Suppl):1834-49. PubMed ID: 192436 [TBL] [Abstract][Full Text] [Related]
11. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells. Aurelian L Cancer Res; 1974 May; 34(5):1126-35. PubMed ID: 4367156 [No Abstract] [Full Text] [Related]
12. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells. Aurelian L Clin Orthop Relat Res; 1974; (99):78-85. PubMed ID: 4363067 [No Abstract] [Full Text] [Related]
13. Correlation between immune complexes and herpes simplex virus (HSV)-tumor associated antigen (TAA) in human cancer sera. Cocchiara R; Tarro G; Flaminio G; Geraci D Cell Mol Biol; 1983; 29(5):397-403. PubMed ID: 6313196 [No Abstract] [Full Text] [Related]
14. Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer. te Velde ER; Aurelian L Tumour Biol; 1987; 8(1):26-33. PubMed ID: 3037680 [TBL] [Abstract][Full Text] [Related]
15. Specific viral antigens in rat cells transformed by herpes simplex virus type 2 and in rat tumors induced by inoculation of transformed cells. Macnab JC; Visser L; Jamieson AT; Hay J Cancer Res; 1980 Jun; 40(6):2074-9. PubMed ID: 6245808 [TBL] [Abstract][Full Text] [Related]
16. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection. Sherlock CH; Ashley RL; Shurtleff ML; Mack KD; Corey L J Clin Microbiol; 1986 Dec; 24(6):1093-7. PubMed ID: 3023439 [TBL] [Abstract][Full Text] [Related]
17. Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma. Aurelian L; Schumann B; Marcus RL; Davis HJ Science; 1973 Jul; 181(4095):161-4. PubMed ID: 4711734 [TBL] [Abstract][Full Text] [Related]
18. Variations of cytotoxic antibodies to cells with herpes simplex virus antigens in women with progressing or regressing cancerous lesions of the cervix. Thiry L; Sprecher-Goldberger S; Fassin Y; Gould I; Gompel C; Pestiau J; De Halleux F Am J Epidemiol; 1974 Oct; 100(4):251-61. PubMed ID: 4370721 [No Abstract] [Full Text] [Related]
19. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells. Christenson B; Espmark A Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115 [TBL] [Abstract][Full Text] [Related]
20. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix. Seth P; Balachandran N Nature; 1980 Aug; 286(5773):613-5. PubMed ID: 6250079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]